Development of 3D phototherapy equipment with led technology for treatment of newborn hyperbilirubinemia

• Grant number: 18/22401-0
• Support Opportunities: Research Grants - Innovative Research in Small Business - PIPE
• Start date: March 01, 2020
• End date: October 31, 2022
• Field of knowledge: Health Sciences - Physiotherapy and Occupational Therapy
• Agreement: FINEP - PIPE/PAPPE Grant
• Principal Investigator: Larissa Camerlengo Dias Gomes
• Grantee: Larissa Camerlengo Dias Gomes
• Company: Led Visual Médica Ltda. - ME
• CNAE: Fabricação de aparelhos eletromédicos e eletroterapêuticos e equipamentos de irradiação ; Fabricação de lâmpadas e outros equipamentos de iluminação
• City: Araraquara
• Associated research grant: 17/50049-7 - Phototerapy equipment development in 3D with LED technology for Hyperbilirrubinemia treatment of newborn, AP.PIPE

Abstract

The objective of the project in question is to enable the commercialization of phototherapy equipment that enables the reduction of bilirubin levels from the latest generation LED technology. The proposed method will offer total coverage to the body area of the newborn, increasing the efficiency and reducing the time needed for the treatment. This device has coupled, in its structure, two LED modules, front and back, as well as, the irradiation control. With this structure, the apparatus is characterized as an illuminating tank that presents innovations based on the tripod, product / process / social. Regarding the product, it has to be changed the design of the equipment necessary for the treatment of jaundice. Currently the market offers illuminators for tub that perform the partial treatment of the body area, the proposed equipment will be an illuminating tub, which allows the total illumination of the newborn. In the aspects related to the process, it is established that the incorporation of the proposed equipment in the health system will lead to a change in the routine of operation of the treatment, the manipulation technique will be changed (the handling of the neonate will be dispensed) and the technique (the irradiation control will be fixed, and the nursing team must control only the exposure time). Finally, in social aspects, there will be a democratization of access to health. With the new technique, time will be gained in the treatments, allowing a greater number of newborns to be attended, reducing treatment costs, given the reduction in application time of at least 35%. It should be emphasized that the proposed innovation is not limited to the eliminators to the LED, but to the proposition of a new form of treatment accompanied by the respective concern with the application technique. (AU)